Patent monopolies are incompatible with a truly free market because there is a prohibition from duplicating an idea or approach or method. The remuneration right model resembles more a free market mechanism because it provides freedom to build on top of other innovators ideas, while the ‘demand’ cap is set at the measurement of health impact.
